News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Xtent Inc. Sets IPO At 4.7 Million Shares, $16-$18 Each


1/11/2007 8:13:01 AM

WASHINGTON, Jan 11 (Reuters) - Xtent Inc., which develops stent systems to treat coronary artery disease, on Thursday set its planned initial public offering at 4.7 million shares for an estimated price of $16 to $18 each.

>>> Discuss This Story


Read at Reuters

comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES